1/76
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
lifestyle modifications
weight reduction
1 mmHg/1 kg lost
goal BMI = 18.5 - 24.9 kg/m2
DASH
5 - 8 mmHg
fruits, veggies, low fat dairy
dietary sodium restriction
6 - 8 mmHg
2300 mg/day (ideal: 1500 mg/day)
K supplementation
5 - 7mmHg
physical activity
4 - 10 mmHg
30 mins/day
moderation of alcohol
4 - 6 mmHg
men = </= 2 drinks/day
women </= 1 drink/day
does smoking directly cause HTN?
no
hypertensive crisis
severe abrupt elevation in BP
> 180 / 120
difference between severe HTN vs hypertensive emergency
presence of end-organ damage = hypertensive emergency
goal of severe HTN
lower BP over 24 - 48 hours
oral meds
goal of hypertensive emergency
reduce SBP 20 - 25% within 1st hour
then
lower to 160/100-110 over next 2 - 6 hours
normalize within 24 - 48 hours
Nitroprusside (Nipride)
class
risks
route
use
avoid
nitric oxide vasodilator
nitric oxide donor
cyanide toxicity, thiocyanate toxicity
IV
use
aortic dissection w/ BB, HF
avoid
acute renal failure, stroke, encephalopathy
nitroglycerin
class
risks
route
use
nitric oxide vasodilator
nitric oxide donor
HA, tachyphylaxis
acute coronary syndrome, HF
Nicardipine (Cardene)
class
use
DHP CCB
acute renal failure, ischemic stroke, encephalopathy, aortic dissection w/ BB, acute coronary syndrome
Clevidipine (Cleviprex)
class
risk
DHP CCB
hypertriglyceridemia
Esmolol (Brevibloc)
class
caution
use
avoid
cardio selective beta blocker
HF, heart block
aortic dissection
use
acute coronary syndrome
avoid
acute HF
Labetalol (Trandate)
class
caution
use
avoid
mixed alpha + beta blocker
acute HF, airway disease
use
acute renal failure, ischemic stroke, hypertensive encephalopathy, aortic dissection, acute coronary syndrome
avoid
acute HF
Fenoldopam (Corlopam)
class
function
use
D1 receptor agonist
increase renal blood flow
acute renal failure
Enalaprilat (Vasotec)
class
caution
avoid
IV ACE inhibitor
acute kidney injury, hyperkalemia, angioedema
acute renal failure
Hydralazine
class
caution
avoid
smooth muscle relaxant
coronary ischemia
avoid
aortic dissection
acute coronary syndrome
Target BP goal
< 130 / 80 mmHg
2 criteria to start meds
BP > /= 140/90 mmHg
BP 130 - 139 / 80 - 89 mmHg + one of the following
CVD
CKD
>/= 7.5% PREVENT score
maintains the same after 3 - 6 months of non-pharm therapy
1st line agents
thiazides
ACEis
ARBs
CCBs (DHPs)
2nd line and Alternative agents
Loop and K+ sparing diuretics
non-DHPs CCBs
beta blocker
alpha blockers
central alpha agonists
direct renin inhibitors
direct vasodilators
diuretics
dosed when?
effects blunted by..
DDI
AM
high sodium diet
lithium
thiazides
place in therapy
CI
ADE
1st line for HTN
poor renal function (GFR < 30 mL/min or SCr > 2.5)
hypokalemia, hypercalcemia, hyperuricemia, hyperglycemia
hydrochlorothiazide
brand
dosing
Microzide
25 - 50mg
chlorthalidone
dose
12.5 - 25 mg
Metolazone
brand
Zaroroxlyn
Loop diuretics
place in therapy
ADE
pearl
preferred in those w/ CKD (GFR < 30), HF, edema
hypokalemia, hypocalcemia, hypmagnesia, hyperuricemia, hyperglycemia
sulfa allergy → use ethacrynic acid
Furosemide
brand
dosing
Lasix
20 - 300 mg
Bumetamide
brand
bumex
Torsemide
brand
Demedex
K+ Sparing Diuretics
place in therapy
ADE
caution
drugs
combo w/ another diuretic
hyperkalemia, hyperuricemia
ACEis, ARBS, direct renin inhibitors, K supplements,
Amiloride, Triamterene
K+ Sparing Diuretics: MRAs
common in HF
caution in impaired kidneys and diabetes w/ proteinuria
Spironolactone
brand
dosing
side effect
aldactone
25 - 100 mg
gynecomastia
Eplerenone
CI
CrCl < 50 mL/min
SCr > 1.8 mg/dL in women
SCr > 2 mg/dL in men
ACEis
MOA
place in therapy
indications
inhibit ACE and inhibit breakdown of bradykinin
1st line HTN
post MI, HF, diabetes, CKD
Lisinopril
brand
dosing
Zestril
10 - 40 mg
Enalapril
brand
dosing
Vasotec
5 - 40 mg
Benazepril
brand
dosing
Lotensin
10 - 40 mg
Ramipril
brand
Altace
Quinapril
brand
Accupril
ARBs
MOA
place in therapy
block ang receptor that mediates ang II
alternative for pts who cannot tolerate ACEi- induced cough
Losartan
brand
dosing
Cozaar
50 - 100 mg
Valsartan
brand
dosing
diovan
80 - 320 mg
Irbesartan
brand
Avapro
Olmesartan
brand
Benicar
direct renin inhibitors
block RAAS at activation
alternative to 1st line
monotherapy or combo
Aliskerin
ACEi/ARB/Direct Renin inhbitors ADE
dry cough - ACEi
hyperkalemia
acute renal failure
changes to GFR
angioedema
avoid in
ARF, renal artery stenosis
pregancy/breastfeeding
CCBs
DHP
inhibits calcium influx
long acting preferred add on for ISH HTN
kinda repeat from Elsaid
Amlodipine
brand
dosing
Norvasc
2.5 - 10 mg
Nifedipine
brand
dosing
Procardia
60 - 120 mg
Diltiazem
brand
dosing
cardiazem
120 - 480 mg
Verapamil
brand
dosing
Calan, Vereian
120 - 480 mg
Beta blockers place in therapy
indications
ADE
clinical pearl
DDI
not inital therapy
add on or alternative
post MI, stable angina, HFrEF
bradycardia, fatigue, sex dysfunction, bronchospasm, mask hypoglycemia effects in diabetics
avoid abrupt discontinuation
taper 1 - 2 weeks
amiodarone and non-DHPs
metoprolol tartrate, metoprolol succinate
brand
dosing
Lopressor, Toprol XL
25 - 400 mg
Atenolol
brand
dosing
Tenormin
25 - 100mg
Carvedilol
brand
dosing
Coreg
6.25 - 50mg
Propranolol
brand
Inderal
Nebivolol
brand
Bystolic
Labetalol
brand
Normodyne
alpha 1 blockers
place in therapy
ADE
clinical pearls
DDI
alternative agents used in combo w/ first line
benefit w/ BPH
1st dose phenomenon, orthostatic hypotension
PTSD nightmares w/ Prazosin, caution w/ elderly
phosphodiesterase-5 inhibitors
Prazosin
Doxazosin
Terazosin
Tamsulosin
Minipress
Carduran
Hytrin
Flomax
central alpha 2 agonist
MOA
place in therapy
Clonidine
Methyldopa
ADE
clinical pearls
stimulate brain receptors
clonidine (Catapress) = resistant HTN
methyldopa = pregancy-induced HTN
edema, anti-SLUD, orthostatic hypotension
avoid abruption → taper, caution in elderly
Direct vasodilators
MOA
place in therapy
ADE
clinical pearl
relax arteriolar muscle
Hydralazine (Apresoline 25 - 100mg)
Minoxidil
tachycardia, edema
same as Elsaid
chronic use in combo w/ diuretic and BB
Efficacy monitoring
re evaluate BP 1 month after starting/changing terapy
safety monitoring
check labs 2 - 4 weeks after starting new agent or increasing dose
combination therapy
when to use
preferred combo
start w/ 2 1st-line drugs for pts w/ stage 2
ACEi/ARB + CCB DHP
ACEi/ARB + diuretic
DO NOT COMBINE ACEi + ARB
Post Mi / stable Angina
BB, ACEi, or ARB
HFeEF
ACEi or ARB, BB, MRA
diabetes or CKD w/ albuminuria
ACEi or ARB
recurrent stroke
thaizide, ACEI, or ARB
resistant HTN
uncontrolled BP being on 3+ drugs at max dose (1 being diuretic)
or
controlled BP requires 4+ agents
Resistant HTN: treatments
rule out anything else
chlorithalidone » HCTZ
loop diuretics in renal dysfuncition
spironolactone = best add on
new therapy = aprocintentan
HTN elderly
low isolated systolic HTN (elevated SBP, normal/low DBP)
treat when < 130/80
risk for AE and orthostatic hypotension
orothostatic hypotension
drop in BP when standing
SBP decrease of > 20 mmHg or DBP decrease of 10 mmHg
treat by low dose and titrate
Midodrine oor Fludrocortisone
gestational HTN
new onset HTN arising mid pregnancy w/ absence of proteinuria
preeclampsia
BP > 140/90 after 20 week gestation w/ proteinuria
treatment
delivery
bed rest + monitoring
IV antihyperensives
eclampsia
onset of convulsions, medical emergency
pregnancy HTN
treatment
CI
nifedipine, labetalol
alternative: methydopa
CI ACEi, ARB. renin inhibitors, atenonol, nitroprusside, MRAs
HTN in children/adolescents
type of HTN
risk factors
treatment
CI
secondary
family hx, overweight
lifestyle modification, reduce to 90th percentile, ACEi/ARB. BB, CCB, thiazides
ACEi/ARB, renin inhibitors in sexually active girls